PUBLISHER: CCM Data & Business Intelligence | PRODUCT CODE: 607204
PUBLISHER: CCM Data & Business Intelligence | PRODUCT CODE: 607204
Strategic planning for carbon dioxide peaking and carbon neutrality has been made by the Chinese authorities, which authorised the drafting of a relevant industry standard and unveiled numerous policies.
NCPC has set foot in the functional beverage market. Its controlled subsidiary, Huawei Health, launched a new product called "Xiongniu Vitamin Energy Drink".
The EI report of Shengda Bio-pharm's "production plant relocation project" was approved in late Sept., which was also publicised by the Ecological Environment Bureau of Taizhou City.
The pre-approval publication of EI report of Tianxin Pharma's "renovation project of vitamin H production line (by introducing intelligent technologies)" was recently made by the Ecological Environment Bureau of Jingdezhen City.
As of late Sept., the EI report of Shangyu Jingxin's 60 t/a vitamin D3 project has been filed for record and accepted by the local environmental authority, which also publicised this EI report.
The EI report of Hebei Donghai's "construction project of headquarters and R&D production base" was approved by the local authority on 28 Sept.
In late Sept., Goto Biopharm released an announcement stating that the company plans to publicly issue convertible bonds in order to raise funds, which will partially be invested in the "construction and production project of progesterone and intermediate bisnoralcohol".
Okay Pharma plans to launch an IPO on BSE. The company's application was accepted on 25 April and was approved after the deliberation of BSE's Listing Committee on 30 Sept.
In Aug., 2022, China's export volume of vitamins dropped by 17.19% MoM, and export values declined by 21.56% MoM.
Bolstered by increased costs of upstream raw material, the price of choline chloride in Oct. climbed month on month.
Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
It is a monthly published newsletter, which can be downloaded in PDF format. The subscription period is yearly, grants the subscriber 12 issues in total.
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China's tougher stance on environmental protection is also having an effect.
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
Breaking news from China and abroad
The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Editor's Note
Governmental Direction
Authorities unveil numerous policies pertinent to carbon dioxide peaking and carbon neutrality
Market Dynamics
NCPC sets foot in functional beverage market
Company Developments
EI report of Shengda Bio-pharm's plant relocation project approved
Tianxin Pharma to upgrade VH production line with intelligent technologies
EI report of Shangyu Jingxin's 60 t/a VD3 project enters approval process
Hebei Donghai: EI report of HQ and R&D production base project approved
Goto Biopharm to raise more funds for bisnoralcohol project by issuing convertible bonds
Okay Pharma to list on BSE
Import and Export Analysis
Imports and exports of selected vitamins in China, Aug. 2022
China's export volume of vitamins in Aug. down 17.19% MoM
Price Update
Ex-works prices of selected vitamins in China, Oct. 2022
Price of choline chloride in Oct. climbs MoM
News in Brief
Lisheng Pharma's folic acid tablet passes consistency evaluation of generic drug
Dafeng Hegno commences 40-day equipment overhaul and production suspension
Guangji Pharm Mengzhou completes overhaul and resumes production
First-time EIA publication of Kingdomway Vitamin's VA derivatives and lipoic acid series project
First-time EIA publication of Zewei Pharma's steroid hormone API project
SZSE suspends vetting process for Minsheng Healthcare's IPO
Jingdong Jingzao launches new product-compound vitamin pill
Chundi Biotech: application for Vegan certification and Halal Accreditation submitted
Xintuoyang Bio: municipal accreditation of pilot-scale experiment base
Taifeng Biotech's "Eldecalcitol Soft Capsule" obtains registration approval